Erratum to: Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants
- PMID: 26377405
- PMCID: PMC4572683
- DOI: 10.1186/s13063-015-0940-6
Erratum to: Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants
Erratum for
-
Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.Trials. 2015 Aug 19;16:365. doi: 10.1186/s13063-015-0891-y. Trials. 2015. PMID: 26285695 Free PMC article. Clinical Trial.
Similar articles
-
Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.Transplant Proc. 2005 May;37(4):1815-7. doi: 10.1016/j.transproceed.2005.02.072. Transplant Proc. 2005. PMID: 15919475
-
Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.J Thorac Cardiovasc Surg. 1990 May;99(5):852-60. J Thorac Cardiovasc Surg. 1990. PMID: 2329823
-
Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.J Urol. 2005 Aug;174(2):703-7. doi: 10.1097/01.ju.0000164752.37118.9c. J Urol. 2005. PMID: 16006954
-
The efficacy and safety of alemtuzumab and daclizumab versus antithymocyte globulin during organ transplantation: a meta-analysis.Transplant Proc. 2012 Dec;44(10):2955-60. doi: 10.1016/j.transproceed.2012.05.085. Transplant Proc. 2012. PMID: 23195005 Review.
-
Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.Mult Scler. 2009 Aug;15(8):951-8. doi: 10.1177/1352458509105426. Epub 2009 May 22. Mult Scler. 2009. PMID: 19465446 Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources